IL33 and cancer: IL-33 and its receptor ST2 are found to co-localize in poorly differentiated human gastric cells; functionally, IL-33 self-stimulation promotes the survival and proliferation of cancer stem cells, supposedly in cooperation with the Wnt-axis, and confers resistance to chemotherapy [118].